17.18 +0.24 (1.41%)
GHDX
Stock Details
Last Trade:17.18 Change:+0.24 (1.41%) Prev Close:16.94 Open: 16.99 Days Range:16.80 – 17.32 52 Week Range: 15.81 - 27.22 Volume:105426 P/E: N/AEPS:-0.40
View AllRecent Alerts 02/10/10
Recent Alert on 02/03/10 at 4:46pm
Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
Genomic Health, Inc. (NASDAQ: GHDX) reports Q4 loss of $0.01, 5 cents better than the analyst estimate of ($0.06). Revenue for the quarter was $39.6 million, which compares to the estimate of $40.35 million. Sees FY10 sales of $180-$190 million,... Read More
Recent Alert on 02/03/10 at 4:46pm
Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
Recent Alert on 02/02/10 at 3:16pm
Trading Radar for 02/03: Cisco (CSCO), ON Semi (ONNN), Visa (V), Novellus (NVLS), Monster Worldwide (MWW) Report
Trading Radar for 02/03: Cisco (CSCO), ON Semi (ONNN), Visa (V), Novellus (NVLS), Monster Worldwide (MWW) Report
Recent Alert on 01/22/10 at 8:43am
Piper Jaffray Upgrades Genomic Health (GHDX) to Overweight; Attractive Valuation
Piper Jaffray Upgrades Genomic Health (GHDX) to Overweight; Attractive Valuation
Recent Alert on 01/21/10 at 9:30am
Genomic Health's (GHDX) Oncotype DX Colon Cancer Test Now Available Worldwide
Genomic Health's (GHDX) Oncotype DX Colon Cancer Test Now Available Worldwide
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/14/09 at 6:47am
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline